Brief Report: Calculating the Ankylosing Spondylitis Disease Activity Score If the Conventional C‐Reactive Protein Level Is Below the Limit of Detection or If High‐Sensitivity C‐Reactive Protein Is Used: An Analysis in the DESIR Cohort
Authors:
Open Access
- 20 October 2014
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 67 (2) , 408-413
Abstract
Objective: The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a composite measure of disease activity in axial spondyloarthritis. The aims of this study were to determine the most appropriate method for calculating the ASDAS using the C‐reactive protein (CRP) level when the conventional CRP level was below the limit of detection, to determine how low CRP values obtained by high‐sensitivity CRP (hsCRP) measurement influence ASDAS‐CRP results, and to test agreement between different ASDAS formulae.Methods: Patients with axial spondyloarthritis who had a conventional CRP level below the limit of detection (5 mg/liter) were selected (n = 257). The ASDAS–conventional CRP with 11 different imputations for the conventional CRP value (range 0–5 mg/liter, at 0.5‐mg/liter intervals) was calculated. The ASDAS‐hsCRP and ASDAS using the erythrocyte sedimentation rate (ESR) were also calculated. Agreement between the ASDAS formulae was tested.Results: The ASDAS‐hsCRP showed better agreement with the ASDAS‐CRP calculated using the conventional CRP imputation values of 1.5 and 2.0 mg/liter and with the ASDAS‐ESR than with other imputed formulae. Disagreement occurred mainly in lower disease activity states (inactive/moderate disease activity). When the CRP value was <2 mg/liter, the resulting ASDAS‐CRP scores may have been inappropriately low.Conclusion: When the conventional CRP level is below the limit of detection or when the hsCRP level is <2 mg/liter, the constant value of 2 mg/liter should be used to calculate the ASDAS‐CRP score. There is good agreement between the ASDAS‐hsCRP and ASDAS‐ESR; however, formulae are not interchangeable.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (SFRH/BD/62329/2009)
- Wyeth (unrestricted grant)
This publication has 15 references indexed in Scilit:
- Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programmeAnnals of the Rheumatic Diseases, 2014
- MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitorAnnals of the Rheumatic Diseases, 2012
- The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patientsJoint Bone Spine, 2011
- ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitorsAnnals of the Rheumatic Diseases, 2011
- Endorsement of Definitions of Disease Activity States and Improvement Scores for the Ankylosing Spondylitis Disease Activity Score: Results from OMERACT 10The Journal of Rheumatology, 2011
- Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort studyArthritis Research & Therapy, 2011
- The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor- inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in ChinaRheumatology, 2011
- Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scoresAnnals of the Rheumatic Diseases, 2011
- ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2009
- Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2009